food and drug administration fda

Order byBest matchMost fresh

FDA Appoints Biotech Exec

Biotech exec George Tidmarsh picked as FDA's chief drug regulator

The U.S. Food and Drug Administration on Monday named ex-biotech industry exec George Tidmarsh as its chief drug regulator.

· 1d

Former biotech executive appointed to lead FDA drug review office

· 1d · on MSN

FDA appoints biotech executive as top drug regulator under RFK Jr.

Sarepta Therapeutics, FDA and gene

Digest more

· 8h · on MSN

Sarepta shares slide again as drugmaker bows to FDA pressure to pause gene therapy

Shares of drugmaker Sarepta Therapeutics continued to sink Tuesday after the company said it would comply with a Food and Drug Administration request to pause shipments of its gene therapy following s...

· 1d

Children's Hospital LA Pauses Use of Sarepta Gene Therapy for All Patients

· 12h

Sarepta Therapeutics’ stock slips further as company bows to FDA pressure to halt shipments

· 10h

Sarepta Faces Fresh Setback. Why Now’s Not the Time to Buy the Stock.

Sarepta Therapeutics was falling again in premarket trading Tuesday as its future looks increasingly shaky after it agreed to halt shipments of its Elevidys drug under pressure from the Food and Drug ...

STAT · 13h

In surprise reversal, Sarepta Therapeutics says it will pause shipments of Duchenne gene therapy

STAT · 1d

Pharmalittle: We’re reading about Sarepta resisting FDA over Elevidys, agency naming top drug regulator, and more

FDA Announces Tuna Salad Recall in 7 States Due To Potential Listeria Contamination

The first recall affects tuna salad and ready-to-eat foods containing tuna salad sold at Jewel-Osco (which is owned by Albertsons) stores in three states: Illinois, Indiana, and Iowa. The second recall affects tuna salad and ready-to-eat foods containing tuna salad sold at three other stores in the Albertsons family,

11hon MSN

Replimune says FDA rejected its lead drug for skin cancer

Replimune (NASDAQ:REPL) announced on Tuesday that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter regarding its marketing application for its lead asset, RP1, declining to approve it as part of a combination regimen for melanoma,

8hon MSN

FDA Issues Risk Warning for Bread Recall Update

The FDA's assessment of the bread recall has designated it as a Class II risk, which means the product "may cause temporary or medically reversible adverse health consequences." However, the classification is also used "where the probability of serious adverse health consequences is remote."

CSP Daily News4h

FDA’s authorization of Juul e-cigarettes prompts mixed responses

Thursday’s authorization, following a multiyear FDA review, has come under scrutiny, including from Yolanda Richardson, president and CEO of Campaign for Tobacco-Free Kids, who called it a “big step” backward for preventing youth e-cigarette use.

Health and Me on MSN2d

"Obsolete And Unnecessary": FDA Set To Revoke 52 Nutrition And Labeling Rules

The FDA plans to revoke 52 outdated nutrition and labeling regulations to streamline food industry standards, citing them as obsolete and no longer necessary for modern practices.

1don MSN

FDA Suspends Muscular Dystrophy Drug After 3 Patient Deaths

The U.S. Food and Drug Administration ( FDA) has placed an immediate clinical hold on Sarepta Therapeutics' investigational gene therapy trials for limb girdle muscular dystrophy following three patient deaths potentially linked to the company's treatments.

TAG24 on MSN4d

Food and Drug Administration may soon revise hormone replacement therapy warnings

US Food and Drug Administration Commissioner Marty Makary signaled Thursday that he is open to revising strict warning labels on Hormone Replacement Therapy.

JD Supra4d

FDA Regulatory Updates for Summer 2025: Food, Supplements, and Cosmetics

Recent actions by the Food and Drug Administration (FDA or Agency) reflect a sharpened scrutiny in areas where public health and safety may